The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Galactorrhoea 4
SANDOSTATIN LAR DEPOT Gastritis 4
SANDOSTATIN LAR DEPOT General physical condition abnormal 4
SANDOSTATIN LAR DEPOT Haemorrhoidal haemorrhage 4
SANDOSTATIN LAR DEPOT Hepatic cyst 4
SANDOSTATIN LAR DEPOT Hepatic failure 4
SANDOSTATIN LAR DEPOT Humerus fracture 4
SANDOSTATIN LAR DEPOT Hyponatraemia 4
SANDOSTATIN LAR DEPOT Increased bronchial secretion 4
SANDOSTATIN LAR DEPOT Infarction 4
SANDOSTATIN LAR DEPOT Injection site oedema 4
SANDOSTATIN LAR DEPOT Intra-abdominal fluid collection 4
SANDOSTATIN LAR DEPOT Laboratory test abnormal 4
SANDOSTATIN LAR DEPOT Lower limb fracture 4
SANDOSTATIN LAR DEPOT Macular fibrosis 4
SANDOSTATIN LAR DEPOT Mammary duct ectasia 4
SANDOSTATIN LAR DEPOT Micturition urgency 4
SANDOSTATIN LAR DEPOT Mood swings 4
SANDOSTATIN LAR DEPOT Multiple organ dysfunction syndrome 4
SANDOSTATIN LAR DEPOT Muscle contusion 4

Total Records: 2,045     Number of Pages: 103